- Market Watch5 days ago
- Market Watch7 days ago
- Medscape5 days ago
Merck Sharp & Dohme Corp. company research & investing information. Find executives and the latest company news.
Merck Sharp & Dohme Corp. (“Merck”) owns U.S. Patent No. 6,127,353, which claims mometasone furoate monohydrate, the active ingredient in Merck’s Nasonex®
The company will provide, free of charge upon request, its Annual Report on Form 10-K which contains the Company's complete audited financial statements.
a major milestone creating the company’s first complete research and development laboratory -- one that was so outstanding that it could “talk on equal terms with the universities and research institutes” -- was a milestone…and not just for the company and george merck, who initiated and led the effort as the company’s president.
- related to Merck Sharp & Dohme Corp